NASDAQ:BSTC
Delisted
BioSpecifics Technologies Corp Stock News
$88.53
+0 (+0%)
At Close: May 27, 2022
Biospecifics Technologies (BSTC) Receives a Buy from H.C. Wainwright
11:10am, Tuesday, 17'th Mar 2020
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Biospecifics Technologies (BSTC – Research Report) today and set a
Barclays PLC Acquires 2,207 Shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC)
09:40am, Tuesday, 17'th Mar 2020
Barclays PLC boosted its holdings in shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 56.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securi
BioSpecifics Technologies Corp. (NASDAQ:BSTC) Shares Purchased by Charles Schwab Investment Management Inc.
08:26am, Tuesday, 17'th Mar 2020
Charles Schwab Investment Management Inc. boosted its stake in BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 11.4% during the 4th quarter, HoldingsChannel reports. The fund owned 54,134 shares of t
BioSpecifics: 4Q Earnings Snapshot
08:12pm, Monday, 16'th Mar 2020
LYNBROOK, N.Y. (AP) _ BioSpecifics Technologies Corp. (BSTC) on Monday reported fourth-quarter profit of $7.4 million. On a per-share basis, the Lynbrook, New York-based company said it had profit of
BioSpecifics: 4Q Earnings Snapshot
08:11pm, Monday, 16'th Mar 2020
LYNBROOK, N.Y. (AP) _ BioSpecifics Technologies Corp. (BSTC) on Monday reported fourth-quarter profit of $7.4 million.
On a per-share basis, the Lynbrook, New York-based company said it had profit of
BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
08:01pm, Monday, 16'th Mar 2020
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product markete
Zacks: BioSpecifics Technologies Corp. (NASDAQ:BSTC) Given $90.00 Consensus Price Target by Brokerages
12:46pm, Monday, 16'th Mar 2020
Shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) have earned an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the company, Zacks Investment Res
Ajo LP Boosts Position in BioSpecifics Technologies Corp. (NASDAQ:BSTC)
10:00am, Friday, 13'th Mar 2020
Ajo LP boosted its holdings in BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 1.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 62,516 shares of the biopharmaceu
Does BioSpecifics Technologies Corp. (NASDAQ:BSTC) Have A Particularly Volatile Share Price?
10:36am, Tuesday, 10'th Mar 2020
If you own shares in BioSpecifics Technologies Corp. (NASDAQ:BSTC) then it's worth thinking about how it contributes...
Chicago Equity Partners LLC Lowers Stock Position in BioSpecifics Technologies Corp. (NASDAQ:BSTC)
05:12pm, Thursday, 05'th Mar 2020
Chicago Equity Partners LLC lowered its position in BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 35.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. T
Aviva PLC Acquires New Holdings in BioSpecifics Technologies Corp. (NASDAQ:BSTC)
09:56am, Saturday, 29'th Feb 2020
Aviva PLC acquired a new stake in BioSpecifics Technologies Corp. (NASDAQ:BSTC) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 35,074 shares
Timing the Market, Is it Possible? - February 26, 2020
02:32pm, Wednesday, 26'th Feb 2020
In the long-run, does consistent market timing really matter to be a successful investor?
Timing the Market, Is it Possible? - February 26, 2020
02:32pm, Wednesday, 26'th Feb 2020
In the long-run, does consistent market timing really matter to be a successful investor?
Eagle Asset Management Inc. Sells 598 Shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC)
10:30am, Tuesday, 25'th Feb 2020
Eagle Asset Management Inc. cut its position in shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 1.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 60,492 shares of
